Cidara Therapeutics skyrockets 1,165% after positive CD388 data and Merck's acquisition bid. Read why CDTX stock is a Hold.

Micah Castelo is a web editor for EdTech: Focus on K-12. Her experience includes education and community news coverage for the Syracuse Post-Standard and international news reporting for the Pulitzer ...

In October 2024 IDB Invest issued a synthetic securitization called Scaling 4 Impact to free up capital. It was the first major MDB to use the technique since the African Development Bank, which ...